Global Corticosteroid Injections for Joint Pain Market Research Report 2023

Report ID: 2009533 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Corticosteroid Injections for Joint Pain Market Overview
    1.1 Product Overview and Scope of Corticosteroid Injections for Joint Pain
    1.2 Corticosteroid Injections for Joint Pain Segment by Type
        1.2.1 Global Corticosteroid Injections for Joint Pain Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Knee & Ankle
        1.2.3 Hip Joint
        1.2.4 Shoulder & Elbow
        1.2.5 Facet Joints of the Spine
        1.2.6 Others
    1.3 Corticosteroid Injections for Joint Pain Segment by Application
        1.3.1 Global Corticosteroid Injections for Joint Pain Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Corticosteroid Injections for Joint Pain Market Size Estimates and Forecasts
        1.4.1 Global Corticosteroid Injections for Joint Pain Revenue 2017-2028
        1.4.2 Global Corticosteroid Injections for Joint Pain Sales 2017-2028
        1.4.3 Corticosteroid Injections for Joint Pain Market Size by Region: 2017 Versus 2021 Versus 2028
2 Corticosteroid Injections for Joint Pain Market Competition by Manufacturers
    2.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Corticosteroid Injections for Joint Pain Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Corticosteroid Injections for Joint Pain Manufacturing Sites, Area Served, Product Type
    2.5 Corticosteroid Injections for Joint Pain Market Competitive Situation and Trends
        2.5.1 Corticosteroid Injections for Joint Pain Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Corticosteroid Injections for Joint Pain Players Market Share by Revenue
        2.5.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Corticosteroid Injections for Joint Pain Retrospective Market Scenario by Region
    3.1 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
        3.3.1 North America Corticosteroid Injections for Joint Pain Sales by Country
        3.3.2 North America Corticosteroid Injections for Joint Pain Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
        3.4.1 Europe Corticosteroid Injections for Joint Pain Sales by Country
        3.4.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Region
        3.5.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region
        3.5.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
        3.6.1 Latin America Corticosteroid Injections for Joint Pain Sales by Country
        3.6.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
        3.7.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country
        3.7.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Corticosteroid Injections for Joint Pain Historic Market Analysis by Type
    4.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)
    4.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2022)
    4.3 Global Corticosteroid Injections for Joint Pain Price by Type (2017-2022)
5 Global Corticosteroid Injections for Joint Pain Historic Market Analysis by Application
    5.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)
    5.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2022)
    5.3 Global Corticosteroid Injections for Joint Pain Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Allergan
        6.1.1 Allergan Corporation Information
        6.1.2 Allergan Description and Business Overview
        6.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Allergan Corticosteroid Injections for Joint Pain Product Portfolio
        6.1.5 Allergan Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Pfizer Corticosteroid Injections for Joint Pain Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Sanofi
        6.3.1 Sanofi Corporation Information
        6.3.2 Sanofi Description and Business Overview
        6.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Sanofi Corticosteroid Injections for Joint Pain Product Portfolio
        6.3.5 Sanofi Recent Developments/Updates
    6.4 Anika Therapeutics
        6.4.1 Anika Therapeutics Corporation Information
        6.4.2 Anika Therapeutics Description and Business Overview
        6.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
        6.4.5 Anika Therapeutics Recent Developments/Updates
    6.5 Ferring
        6.5.1 Ferring Corporation Information
        6.5.2 Ferring Description and Business Overview
        6.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Ferring Corticosteroid Injections for Joint Pain Product Portfolio
        6.5.5 Ferring Recent Developments/Updates
    6.6 Bioventus
        6.6.1 Bioventus Corporation Information
        6.6.2 Bioventus Description and Business Overview
        6.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Bioventus Corticosteroid Injections for Joint Pain Product Portfolio
        6.6.5 Bioventus Recent Developments/Updates
    6.7 Flexion Therapeutics
        6.6.1 Flexion Therapeutics Corporation Information
        6.6.2 Flexion Therapeutics Description and Business Overview
        6.6.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
        6.7.5 Flexion Therapeutics Recent Developments/Updates
    6.8 Zimmer Biomet
        6.8.1 Zimmer Biomet Corporation Information
        6.8.2 Zimmer Biomet Description and Business Overview
        6.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Portfolio
        6.8.5 Zimmer Biomet Recent Developments/Updates
    6.9 SEIKAGAKU
        6.9.1 SEIKAGAKU Corporation Information
        6.9.2 SEIKAGAKU Description and Business Overview
        6.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Portfolio
        6.9.5 SEIKAGAKU Recent Developments/Updates
    6.10 Chugai Pharma
        6.10.1 Chugai Pharma Corporation Information
        6.10.2 Chugai Pharma Description and Business Overview
        6.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Portfolio
        6.10.5 Chugai Pharma Recent Developments/Updates
7 Corticosteroid Injections for Joint Pain Manufacturing Cost Analysis
    7.1 Corticosteroid Injections for Joint Pain Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain
    7.4 Corticosteroid Injections for Joint Pain Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Corticosteroid Injections for Joint Pain Distributors List
    8.3 Corticosteroid Injections for Joint Pain Customers
9 Corticosteroid Injections for Joint Pain Market Dynamics
    9.1 Corticosteroid Injections for Joint Pain Industry Trends
    9.2 Corticosteroid Injections for Joint Pain Market Drivers
    9.3 Corticosteroid Injections for Joint Pain Market Challenges
    9.4 Corticosteroid Injections for Joint Pain Market Restraints
10 Global Market Forecast
    10.1 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Corticosteroid Injections for Joint Pain by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Corticosteroid Injections for Joint Pain by Type (2023-2028)
    10.2 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Corticosteroid Injections for Joint Pain by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Corticosteroid Injections for Joint Pain by Application (2023-2028)
    10.3 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Corticosteroid Injections for Joint Pain by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Corticosteroid Injections for Joint Pain by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Corticosteroid Injections for Joint Pain Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Corticosteroid Injections for Joint Pain Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Corticosteroid Injections for Joint Pain Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Corticosteroid Injections for Joint Pain Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Corticosteroid Injections for Joint Pain Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Corticosteroid Injections for Joint Pain Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Corticosteroid Injections for Joint Pain Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Corticosteroid Injections for Joint Pain Manufacturing Sites and Area Served
    Table 11. Manufacturers Corticosteroid Injections for Joint Pain Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Corticosteroid Injections for Joint Pain by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
    Table 16. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)
    Table 17. Global Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2022)
    Table 19. North America Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 20. North America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)
    Table 21. North America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)
    Table 23. Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)
    Table 25. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)
    Table 33. Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2022)
    Table 39. Global Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
    Table 40. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2022)
    Table 41. Global Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Corticosteroid Injections for Joint Pain Revenue Share by Type (2017-2022)
    Table 43. Global Corticosteroid Injections for Joint Pain Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Corticosteroid Injections for Joint Pain Sales (K Units) by Application (2017-2022)
    Table 45. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2022)
    Table 46. Global Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Corticosteroid Injections for Joint Pain Revenue Share by Application (2017-2022)
    Table 48. Global Corticosteroid Injections for Joint Pain Price by Application (2017-2022) & (USD/Unit)
    Table 49. Allergan Corporation Information
    Table 50. Allergan Description and Business Overview
    Table 51. Allergan Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Allergan Corticosteroid Injections for Joint Pain Product
    Table 53. Allergan Recent Developments/Updates
    Table 54. Pfizer Corporation Information
    Table 55. Pfizer Description and Business Overview
    Table 56. Pfizer Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Pfizer Corticosteroid Injections for Joint Pain Product
    Table 58. Pfizer Recent Developments/Updates
    Table 59. Sanofi Corporation Information
    Table 60. Sanofi Description and Business Overview
    Table 61. Sanofi Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Sanofi Corticosteroid Injections for Joint Pain Product
    Table 63. Sanofi Recent Developments/Updates
    Table 64. Anika Therapeutics Corporation Information
    Table 65. Anika Therapeutics Description and Business Overview
    Table 66. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Anika Therapeutics Corticosteroid Injections for Joint Pain Product
    Table 68. Anika Therapeutics Recent Developments/Updates
    Table 69. Ferring Corporation Information
    Table 70. Ferring Description and Business Overview
    Table 71. Ferring Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Ferring Corticosteroid Injections for Joint Pain Product
    Table 73. Ferring Recent Developments/Updates
    Table 74. Bioventus Corporation Information
    Table 75. Bioventus Description and Business Overview
    Table 76. Bioventus Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Bioventus Corticosteroid Injections for Joint Pain Product
    Table 78. Bioventus Recent Developments/Updates
    Table 79. Flexion Therapeutics Corporation Information
    Table 80. Flexion Therapeutics Description and Business Overview
    Table 81. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Flexion Therapeutics Corticosteroid Injections for Joint Pain Product
    Table 83. Flexion Therapeutics Recent Developments/Updates
    Table 84. Zimmer Biomet Corporation Information
    Table 85. Zimmer Biomet Description and Business Overview
    Table 86. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Zimmer Biomet Corticosteroid Injections for Joint Pain Product
    Table 88. Zimmer Biomet Recent Developments/Updates
    Table 89. SEIKAGAKU Corporation Information
    Table 90. SEIKAGAKU Description and Business Overview
    Table 91. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. SEIKAGAKU Corticosteroid Injections for Joint Pain Product
    Table 93. SEIKAGAKU Recent Developments/Updates
    Table 94. Chugai Pharma Corporation Information
    Table 95. Chugai Pharma Description and Business Overview
    Table 96. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Chugai Pharma Corticosteroid Injections for Joint Pain Product
    Table 98. Chugai Pharma Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Corticosteroid Injections for Joint Pain Distributors List
    Table 102. Corticosteroid Injections for Joint Pain Customers List
    Table 103. Corticosteroid Injections for Joint Pain Market Trends
    Table 104. Corticosteroid Injections for Joint Pain Market Drivers
    Table 105. Corticosteroid Injections for Joint Pain Market Challenges
    Table 106. Corticosteroid Injections for Joint Pain Market Restraints
    Table 107. Global Corticosteroid Injections for Joint Pain Sales Forecast by Type (2023-2028) & (K Units)
    Table 108. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Corticosteroid Injections for Joint Pain Sales Forecast by Application (2023-2028) & (K Units)
    Table 112. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Corticosteroid Injections for Joint Pain Sales Forecast by Region (2023-2028) & (K Units)
    Table 116. Global Corticosteroid Injections for Joint Pain Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Corticosteroid Injections for Joint Pain Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Corticosteroid Injections for Joint Pain Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Corticosteroid Injections for Joint Pain
    Figure 2. Global Corticosteroid Injections for Joint Pain Market Share by Type in 2021 & 2028
    Figure 3. Knee & Ankle Product Picture
    Figure 4. Hip Joint Product Picture
    Figure 5. Shoulder & Elbow Product Picture
    Figure 6. Facet Joints of the Spine Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Corticosteroid Injections for Joint Pain Market Share by Application in 2021 & 2028
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. Global Corticosteroid Injections for Joint Pain Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Corticosteroid Injections for Joint Pain Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Corticosteroid Injections for Joint Pain Sales (2017-2028) & (K Units)
    Figure 15. Corticosteroid Injections for Joint Pain Sales Share by Manufacturers in 2021
    Figure 16. Global Corticosteroid Injections for Joint Pain Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Corticosteroid Injections for Joint Pain Players: Market Share by Revenue in 2021
    Figure 18. Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2022)
    Figure 20. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region in 2021
    Figure 21. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2022)
    Figure 22. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region in 2021
    Figure 23. U.S. Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. U.A.E Corticosteroid Injections for Joint Pain Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Corticosteroid Injections for Joint Pain by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Corticosteroid Injections for Joint Pain
    Figure 49. Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain
    Figure 50. Corticosteroid Injections for Joint Pain Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma
Frequently Asked Questions
Corticosteroid Injections for Joint Pain report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Corticosteroid Injections for Joint Pain report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Corticosteroid Injections for Joint Pain report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports